Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$68.53 - $87.91 $5,550 - $7,120
81 New
81 $6.83 Million
Q4 2023

Jan 24, 2024

BUY
$49.57 - $72.63 $286,762 - $420,164
5,785 New
5,785 $81,000
Q2 2021

Jul 14, 2021

SELL
$113.03 - $155.64 $33,682 - $46,380
-298 Closed
0 $0
Q4 2020

Jan 22, 2021

BUY
$80.55 - $106.05 $24,003 - $31,602
298 New
298 $29.6 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.96B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track International Assets Investment Management, LLC Portfolio

Follow International Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.